Revive Therapeutics Updates, on Phase III Clinical Trial!
Michael Frank, CEO of the Company commented, "We are now in the final stages in our Phase 3 study.."
Revive Therapeutics (RVVTF) Provides Update of Psilocybin Pharmaceutical Programs
IRB approval to initiate Phase 2 study for methamphetamine abuse disordersAdvancing psilocybin oral thin film, microneedle patch and biosynthesis programs
Tax Loss Selling Bargain? Adding Aditxt (ADTX).
Adding Aditxt (ADTX) to the upcoming "2022 Biotech 6-Pack, Stocks We Expect to Double" Watch List.
Dalrada (DFCO). Our 11th and Latest Ten Bagger.
We've actually had many more than 11 ten-baggers, as we report on companies which aren't clients. This is our 11th client we...
The Race to Develop Therapeutics for COVID. The Small Caps Fight for a Treatment...
The Second Wave: Biopharma Players Race to Develop Therapeutics for COVID-19 (BioSPace) December 21.
Revive Therapeutics (RVTTF), RedHill BioPharma...
Revive Therapeutics (RVVTF, RVV.CN) in Discussions to Secure Supply of 5 Billion Bucillamine Tablets.
Revive Therapeutics Provides Update on FDA Phase 3 Clinical Trial for Bucillamine in COVID-19
Not wanting to be caught...
Aphex BioCleanse Systems (SNST) Issued Patent for Sustainable, Reusable Open-Cell Foams for Disinfection of...
PITTSFORD, N.Y., September 14, 2021 - Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company"), a cleaning solutions company focused on the development...
Aditxt, (ADTX) Inc. Working on Antiviral Oral Therapy for COVID-19.
Target Acquisition Has Operational and Sales Footprint in Europe, Asia, and the Middle East
LIVE QUOTE
Up 2,950% is Novavax (NVAX) Still a Buy?
Up 4,002% at it's peak from where we added it to the Corona Stock Review Watch List at 7.80, Thomas Niel from...
Citius Pharma (CTXR) Flexes Muscle in Business Update. Remains Our Top Idea.
Added to Watch List November 2019 @$0.55.
Named Our Top Idea in 2020 @$1.02.Remains Our Top Idea in 2021...